Skip to content
10-Q

Quarterly Report

Beam Therapeutics Inc. BEAM

0000950170-25-102393

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 29, 2025 101.16M sh
Shares Diluted Q2 2025 · Jun 30, 2025 102M sh
Shares Diluted Q2 2025 · Jun 30, 2025 95.02M sh
Shares Diluted Q2 2025 · Jun 30, 2024 82.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 82.01M sh
Capex Q2 2025 · Jun 30, 2025 $6.2M
Capex Q2 2025 · Jun 30, 2024 $4.4M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$180.33M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$182.76M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $282.13M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $281.97M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $292.76M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.05B
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.12B
Stockholders Equity Q2 2025 · Dec 31, 2024 $733.55M
Stockholders Equity Q2 2025 · Jun 30, 2024 $854.09M
Stockholders Equity Q2 2025 · Mar 31, 2024 $913.49M
Stockholders Equity Q2 2025 · Dec 31, 2023 $981.33M
Current Liabilities Q2 2025 · Jun 30, 2025 $174.13M
Current Liabilities Q2 2025 · Dec 31, 2024 $182.07M
Total Liabilities Q2 2025 · Jun 30, 2025 $344.34M
Total Liabilities Q2 2025 · Dec 31, 2024 $370.28M
Current Assets Q2 2025 · Jun 30, 2025 $1.18B
Current Assets Q2 2025 · Dec 31, 2024 $878.15M
Total Assets Q2 2025 · Jun 30, 2025 $1.39B
Total Assets Q2 2025 · Dec 31, 2024 $1.1B
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.23
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.11
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.31
Eps Basic Q2 2025 · Jun 30, 2025 −$1.00
Eps Basic Q2 2025 · Jun 30, 2025 −$2.23
Eps Basic Q2 2025 · Jun 30, 2024 −$1.11
Eps Basic Q2 2025 · Jun 30, 2024 −$2.31
Sga Expense Q2 2025 · Jun 30, 2025 $26.86M
Sga Expense Q2 2025 · Jun 30, 2025 $54.8M
Sga Expense Q2 2025 · Jun 30, 2024 $29.63M
Sga Expense Q2 2025 · Jun 30, 2024 $56.35M
Rd Expense Q2 2025 · Jun 30, 2025 $101.76M
Rd Expense Q2 2025 · Jun 30, 2025 $200.57M
Rd Expense Q2 2025 · Jun 30, 2024 $87.04M
Rd Expense Q2 2025 · Jun 30, 2024 $171.86M
Net Income Q2 2025 · Jun 30, 2025 −$102.29M
Net Income Q2 2025 · Jun 30, 2025 −$211.56M
Net Income Q2 2025 · Mar 31, 2025 −$109.27M
Net Income Q2 2025 · Jun 30, 2024 −$91.05M
Net Income Q2 2025 · Jun 30, 2024 −$189.72M
Net Income Q2 2025 · Mar 31, 2024 −$98.67M
Operating Income Q2 2025 · Jun 30, 2025 −$120.15M
Operating Income Q2 2025 · Jun 30, 2025 −$239.44M
Operating Income Q2 2025 · Jun 30, 2024 −$104.9M
Operating Income Q2 2025 · Jun 30, 2024 −$209.03M
Revenue Q2 2025 · Jun 30, 2025 $8.47M
Revenue Q2 2025 · Jun 30, 2025 $15.94M
Revenue Q2 2025 · Jun 30, 2024 $11.77M
Revenue Q2 2025 · Jun 30, 2024 $19.18M